Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
前收盤價
US$18.25
+US$0.56 · +3.17%
盤後
US$18.25
US$0.00 · 0.00%
10月12日 下午5:30 ET
盤中時間採用ET。市場資料可能有所延遲。
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
日內區間
目前US$18.25
52週區間
目前US$18.25
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 22.48億 USD | 21.08億 USD | 17.07億 USD | 15.63億 USD | 14.26億 USD |
| 銷貨成本 | 9.03億 USD | 9.27億 USD | 7.16億 USD | 6.94億 USD | 6.49億 USD |
| 毛利 | 13.45億 USD | 11.81億 USD | 9.91億 USD | 8.69億 USD | 7.78億 USD |
| 研究與開發 | 1.2億 USD | 9129.8萬 USD | 7533.1萬 USD | 6082.7萬 USD | 4909.4萬 USD |
| 銷售、一般及管理費用 | 10.7億 USD | 9.39億 USD | 8.3億 USD | 7.73億 USD | 6.66億 USD |
| 營業費用 | 13.64億 USD | 19.56億 USD | 10.56億 USD | 9.41億 USD | 8.4億 USD |
| 利息收入 | — | — | — | 20萬 USD | — |
| 利息支出 | 3482.3萬 USD | 5710萬 USD | 1974.9萬 USD | 2495.2萬 USD | 2911.2萬 USD |
| 折舊和攤銷 | 2.94億 USD | 2.85億 USD | 2.17億 USD | 2.2億 USD | 2.63億 USD |
| 營業利益 | −1886.9萬 USD | −7.76億 USD | −6570.9萬 USD | −7117.8萬 USD | −6279.9萬 USD |
| 淨利 | −11.84億 USD | −8.25億 USD | −3326.1萬 USD | −1329.2萬 USD | 7165.7萬 USD |
公司資料更新於 2026年10月13日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動,並非 GoAI 建議。
平均目標
US$36.33
上漲空間 99.07%| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 2022年4月5日 | 1:3 | — | — |
已生效 2022年4月5日
1:3
報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI4276.84萬0.00%2.3兆 USD0.03%US$381.57-0.10%
Avantis U.S. Small Cap Value ETFAVUV4041.41萬0.13%308.51億 USD0.25%US$119.94+0.25%
Vanguard Morningstar Small-Cap ETFVB3091.59萬0.02%1853億 USD0.03%US$288.16-0.46%
iShares Russell 2000 ETFIWM2664.62萬0.03%787.4億 USD0.19%US$277.9-0.37%
Vanguard Morningstar Small-Cap Value ETFVBR1964.89萬0.03%682億 USD0.05%US$234.71+0.12%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV1661.43萬0.06%268.09億 USD0.33%US$37.98+0.08%
Vanguard Extended Market ETFVXF1644.49萬0.02%954億 USD0.05%US$233.52-0.63%
Dimensional - US Targeted Value ETFDFAT954.89萬0.03%301.22億 USD0.33%US$67.42+0.22%
Vanguard Morningstar Total Stock Market ETFVTI
Avantis U.S. Small Cap Value ETFAVUV
Vanguard Morningstar Small-Cap ETFVB
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap Value ETFVBR
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Extended Market ETFVXF
Dimensional - US Targeted Value ETFDFATAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。